IRIS
NAVARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.810
NA - Nord America 1.138
EU - Europa 616
SA - Sud America 163
AF - Africa 36
OC - Oceania 14
Totale 6.777
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.720
US - Stati Uniti d'America 1.068
CN - Cina 509
HK - Hong Kong 362
GB - Regno Unito 154
IT - Italia 147
BR - Brasile 123
DE - Germania 82
VN - Vietnam 82
NL - Olanda 62
CA - Canada 42
IN - India 40
FI - Finlandia 35
MX - Messico 26
JP - Giappone 20
AT - Austria 19
TR - Turchia 18
ES - Italia 16
PL - Polonia 16
UA - Ucraina 16
FR - Francia 15
AR - Argentina 14
ID - Indonesia 14
ZA - Sudafrica 14
AU - Australia 12
BD - Bangladesh 12
LT - Lituania 11
EC - Ecuador 10
EG - Egitto 9
RU - Federazione Russa 8
CO - Colombia 6
DK - Danimarca 6
PE - Perù 6
CZ - Repubblica Ceca 5
SE - Svezia 5
IL - Israele 4
BG - Bulgaria 3
EE - Estonia 3
IR - Iran 3
LB - Libano 3
MA - Marocco 3
RO - Romania 3
TH - Thailandia 3
TL - Timor Orientale 3
TN - Tunisia 3
UZ - Uzbekistan 3
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
NC - Nuova Caledonia 2
PH - Filippine 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
BJ - Benin 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CV - Capo Verde 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IE - Irlanda 1
IS - Islanda 1
KE - Kenya 1
KR - Corea 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NO - Norvegia 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
YT - Mayotte 1
Totale 6.777
Salva come PNG Salva come JPEG
Città #
Hong Kong 355
Singapore 331
Dallas 262
Hefei 256
Ashburn 187
Boardman 135
London 120
Shanghai 81
Council Bluffs 73
Beijing 71
Amsterdam 52
Munich 50
Rome 41
Los Angeles 37
Ho Chi Minh City 36
Santa Clara 22
Turku 22
Toronto 18
Ankara 16
Hanoi 16
San Francisco 16
Bari 15
Pune 15
São Paulo 15
Tokyo 15
Washington 15
Brooklyn 14
New York 14
Warsaw 14
Mexico City 13
Atlanta 12
Helsinki 12
Chennai 11
Hangzhou 10
Boston 9
Seattle 9
Chicago 8
Haiphong 8
Jaguariúna 8
Jinan 8
Nuremberg 8
Qingdao 8
West Jordan 8
Changsha 7
Guangzhou 7
Johannesburg 7
Leicester 7
Montreal 7
Charlotte 6
Las Vegas 6
Melbourne 6
Milan 6
Naples 6
Paris 5
Pisa 5
Vienna 5
Brno 4
Chaozhou 4
Cotia 4
Hải Dương 4
Kongens Lyngby 4
Noicattaro 4
Secaucus 4
State College 4
Stockholm 4
Sydney 4
Xi'an 4
Buenos Aires 3
Cape Town 3
Chengdu 3
Denver 3
Dili 3
Frankfurt am Main 3
Manaus 3
New Delhi 3
Poplar 3
Redmond 3
Shijiazhuang 3
Tel Aviv 3
Tunis 3
Alexandria 2
Anantapur 2
Barcelona 2
Blumenau 2
Bosco Marengo 2
Brest 2
Brisbane 2
Burlington 2
Cairo 2
Calgary 2
Can Tho 2
Chiang Mai 2
Cuernavaca 2
Fisciano 2
Groningen 2
Guayaquil 2
Guiyang 2
Haikou 2
Hammersmith 2
Herne Bay 2
Totale 2.649
Salva come PNG Salva come JPEG
Nome #
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 203
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 196
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 195
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 190
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 185
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 178
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 172
Leptin in immuno-rheumatological diseases 170
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 166
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 165
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 151
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 145
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 123
Personal attitudes and denialist views about the COVID-19 pandemic in Italy: a national survey 119
Adult-onset Still's disease with elderly onset: results from a multicentre study 117
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 113
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 99
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 98
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 96
A longitudinal study on caring behaviors of Italian nursing students 94
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 94
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 88
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 88
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 88
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 87
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 87
Beauty is not perfection: what Leonardo’s Lady with an Ermine can suggest to aesthetic surgery 87
Cannabinoids in Autoimmune and Rheumatic Diseases 86
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 84
Leptin in autoimmune mechanisms of systemic rheumatic diseases 83
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 81
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 76
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 67
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 64
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 63
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 62
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 57
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 51
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 51
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 48
Polypharmacy is a determinant of hospitalization in Parkinson's disease 46
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 45
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 43
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 41
Development and implementation of the AIDA International Registry for patients with Behçet's disease 39
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 39
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 37
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 36
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 35
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 35
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 34
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 33
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 33
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 33
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 33
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 33
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 32
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 32
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 32
The Association of Olfactory Dysfunction, Frailty, and Mortality Is Mediated by Inflammation: Results from the InCHIANTI Study 32
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 32
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 31
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 31
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 31
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 31
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 30
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 30
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 30
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 30
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 29
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 29
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 29
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 28
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future 28
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients 28
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features 27
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 27
Matters of the heart: The case of TNF-alpha targeting drugs 27
Inflammation as a mediator of the association between osteoporosis and hearing loss in older subjects: a population-based study 27
LOW-DOSE ASPIRIN MAY HAVE A ROLE AS PRIMARY PROPHYLAXIS OF CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: EVIDENCE FROM AN ITALIAN MULTICENTRIC RETROSPECTIVE STUDY 27
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 26
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 26
Endothelial-to-mesenchymal transition in systemic sclerosis 26
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 26
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 25
Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis 25
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 25
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 25
Utility of ultrasound in the diagnosis of chronic worsened gout 24
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 24
Pathogenesis of Psoriatic Arthritis 24
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 24
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 24
Tumour necrosis factor alpha (TNFα)cardiomyocyte preconditioning: clues to explain anti-TNFα agents contraindication in severe heart failure 24
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 24
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 24
Targeted synthetic pharmacotherapy for psoriatic arthritis: state of the art 24
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 24
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis 24
Metabolic syndrome is associated with better quality of sleep in the oldest old: results from the "Mugello Study" 23
Totale 6.263
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.057
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 1 2 0 0 0 2 4 21 6 2 81
2022/2023165 1 0 5 4 60 0 6 5 6 7 63 8
2023/2024422 16 53 18 50 45 164 8 18 7 12 21 10
2024/20254.807 49 58 141 90 92 131 73 21 321 328 1.545 1.958
2025/20261.388 490 229 479 190 0 0 0 0 0 0 0 0
Totale 6.901